Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

Sodium thiosulfate attenuates angiotensin II-induced hypertension, proteinuria and renal damage.

Snijder PM, Frenay AR, Koning AM, Bachtler M, Pasch A, Kwakernaak AJ, van den Berg E, Bos EM, Hillebrands JL, Navis G, Leuvenink HG, van Goor H.

Nitric Oxide. 2014 Nov 15;42:87-98. doi: 10.1016/j.niox.2014.10.002. Epub 2014 Oct 16.

PMID:
25459997
2.

Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes.

Dullaart RP, de Vries R, Kwakernaak AJ, Perton F, Dallinga-Thie GM.

Eur J Clin Invest. 2015 Jan;45(1):36-44. doi: 10.1111/eci.12377.

PMID:
25402623
3.

Perceived Barriers and Support Strategies for Reducing Sodium Intake in Patients with Chronic Kidney Disease: a Qualitative Study.

Meuleman Y, Ten Brinke L, Kwakernaak AJ, Vogt L, Rotmans JI, Bos WJ, van der Boog PJ, Navis G, van Montfrans GA, Hoekstra T, Dekker FW, van Dijk S.

Int J Behav Med. 2014 Oct 9. [Epub ahead of print]

PMID:
25298022
4.

Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.

Humalda JK, Lambers Heerspink HJ, Kwakernaak AJ, Slagman MC, Waanders F, Vervloet MG, Ter Wee PM, Navis G, de Borst MH; NIGRAM Consortium.

Am J Kidney Dis. 2015 Feb;65(2):259-66. doi: 10.1053/j.ajkd.2014.07.022. Epub 2014 Sep 30.

PMID:
25278093
5.

Hepatic syndecan-1 changes associate with dyslipidemia after renal transplantation.

Adepu S, Katta K, Tietge UJ, Kwakernaak AJ, Dam W, van Goor H, Dullaart RP, Navis GJ, Bakker SJ, van den Born J.

Am J Transplant. 2014 Oct;14(10):2328-38. doi: 10.1111/ajt.12842. Epub 2014 Aug 25.

PMID:
25154787
6.

Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial.

Kwakernaak AJ, Krikken JA, Binnenmars SH, Visser FW, Hemmelder MH, Woittiez AJ, Groen H, Laverman GD, Navis G; Holland Nephrology Study (HONEST) Group.

Lancet Diabetes Endocrinol. 2014 May;2(5):385-95. doi: 10.1016/S2213-8587(14)70030-0. Epub 2014 Mar 5.

PMID:
24795252
7.

Plasma proprotein convertase subtilisin-kexin type 9 is predominantly related to intermediate density lipoproteins.

Kwakernaak AJ, Lambert G, Dullaart RP.

Clin Biochem. 2014 May;47(7-8):679-82. doi: 10.1016/j.clinbiochem.2014.03.008. Epub 2014 Mar 26.

PMID:
24680982
8.

Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: implications for cardiac outcome.

Dullaart RP, Tietge UJ, Kwakernaak AJ, Dikkeschei BD, Perton F, Tio RA.

Atherosclerosis. 2014 May;234(1):185-92. doi: 10.1016/j.atherosclerosis.2014.02.026. Epub 2014 Mar 11.

PMID:
24661908
9.

The relationship of the anti-oxidant bilirubin with free thyroxine is modified by insulin resistance in euthyroid subjects.

Deetman PE, Bakker SJ, Kwakernaak AJ, Navis G, Dullaart RP; PREVEND Study Group.

PLoS One. 2014 Mar 3;9(3):e90886. doi: 10.1371/journal.pone.0090886. eCollection 2014.

10.

Body mass index and body fat distribution as renal risk factors: a focus on the role of renal haemodynamics.

Kwakernaak AJ, Toering TJ, Navis G.

Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv42-9. doi: 10.1093/ndt/gft331. Review.

PMID:
24179015
11.

The Biobank of Nephrological Diseases in the Netherlands cohort: the String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands.

Navis GJ, Blankestijn PJ, Deegens J, De Fijter JW, Homan van der Heide JJ, Rabelink T, Krediet RT, Kwakernaak AJ, Laverman GD, Leunissen KM, van Paassen P, Vervloet MG, Wee PM, Wetzels JF, Zietse R, van Ittersum FJ; BIND-NL investigators.

Nephrol Dial Transplant. 2014 Jun;29(6):1145-50. doi: 10.1093/ndt/gft307. Epub 2013 Oct 22. Review.

PMID:
24151018
12.

Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients.

Kwakernaak AJ, Waanders F, Slagman MC, Dokter MM, Laverman GD, de Boer RA, Navis G.

J Hypertens. 2013 Dec;31(12):2425-32. doi: 10.1097/HJH.0b013e328364f5de.

PMID:
24029871
13.

The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome.

Dullaart RP, Kwakernaak AJ, Dallinga-Thie GM.

Atherosclerosis. 2013 Sep;230(1):6-11. doi: 10.1016/j.atherosclerosis.2013.06.019. Epub 2013 Jul 1.

PMID:
23958245
14.

Plasma lipoprotein-associated phospholipase A2 mass is elevated in STEMI compared to non-STEMI patients but does not discriminate between myocardial infarction and non-cardiac chest pain.

Dullaart RP, van Pelt LJ, Kwakernaak AJ, Dikkeschei BD, van der Horst IC, Tio RA.

Clin Chim Acta. 2013 Sep 23;424:136-40. doi: 10.1016/j.cca.2013.05.026. Epub 2013 Jun 10.

PMID:
23756128
15.

Low-normal free thyroxine confers decreased serum bilirubin in type 2 diabetes mellitus.

Deetman PE, Kwakernaak AJ, Bakker SJ, Dullaart RP.

Thyroid. 2013 Nov;23(11):1367-73. doi: 10.1089/thy.2013.0156. Epub 2013 Sep 4.

16.

Low normal thyroid function enhances plasma cholesteryl ester transfer in Type 2 diabetes mellitus.

Triolo M, Kwakernaak AJ, Perton FG, de Vries R, Dallinga-Thie GM, Dullaart RP.

Atherosclerosis. 2013 Jun;228(2):466-71. doi: 10.1016/j.atherosclerosis.2013.03.009. Epub 2013 Apr 6.

PMID:
23591416
17.

Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index.

Kwakernaak AJ, Zelle DM, Bakker SJ, Navis G.

J Am Soc Nephrol. 2013 May;24(6):987-94. doi: 10.1681/ASN.2012050460. Epub 2013 Apr 11.

18.

Creatinine excretion rate and mortality in type 2 diabetes and nephropathy.

Sinkeler SJ, Kwakernaak AJ, Bakker SJ, Shahinfar S, Esmatjes E, de Zeeuw D, Navis G, Lambers Heerspink HJ.

Diabetes Care. 2013 Jun;36(6):1489-94. doi: 10.2337/dc12-1545. Epub 2013 Jan 8.

19.

Low normal free T4 confers decreased high-density lipoprotein antioxidative functionality in the context of hyperglycaemia.

Triolo M, de Boer JF, Annema W, Kwakernaak AJ, Tietge UJ, Dullaart RP.

Clin Endocrinol (Oxf). 2013 Sep;79(3):416-23. doi: 10.1111/cen.12138. Epub 2013 May 11.

PMID:
23278171
20.

Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: relationship with lipoprotein response to antiproteinuric treatment.

Kwakernaak AJ, Lambert G, Slagman MC, Waanders F, Laverman GD, Petrides F, Dikkeschei BD, Navis G, Dullaart RP.

Atherosclerosis. 2013 Feb;226(2):459-65. doi: 10.1016/j.atherosclerosis.2012.11.009. Epub 2012 Nov 29.

PMID:
23261172
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk